GERI-BP002-A
GERI-BP002-A is an inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT) produced by Aspergillus fumigatus F93, which can be used in cancer research[1].
Product Specifications
CAS Number
[119-47-1]
UNSPSC
12352005
Hazard Statement
H360
Target
Acyltransferase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/geri-bp002-a.html
Concentration
10mM
Purity
99.77
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC1=C(C(C)(C)C)C=C(C)C=C1CC2=CC(C)=CC(C(C)(C)C)=C2O
Molecular Formula
C23H32O2
Molecular Weight
340.50
Precautions
H360
References & Citations
[1]Kim Y K, et al. GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93[J]. The Journal of Antibiotics, 1996, 49 (1) : 31-36.
Shipping Conditions
Room Temperature
Storage Conditions
RT, stored under nitrogen
Badge
Hot
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6181044-01 0.1 mL
EGR1 (Early Growth Response 1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225) (HRP)
Ask
View Details MBS6181044-02 5x 0.1 mL
EGR1 (Early Growth Response 1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225) (HRP)
Ask
View Details GTR15171010 1 Vial
Lentiviral mouse Ly6g6f shRNA (UAS) - Lentiviral mouse Ly6g6f shRNA (UAS, GFP) plasmid
Ask
View Details 